Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury

Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury

Frontiers in Pharmacology, 2016 · DOI: 10.3389/fphar.2016.00047 · Published: March 8, 2016

Spinal Cord InjuryPharmacologyNeurology

Simple Explanation

Spinal cord injury (SCI) stimulates activation of astrocytes and infiltration of immune cells at the lesion site. The study explores the neuroregenerative properties of co-ultraPEALut in a murine model of SCI. Mice were treated with co-ultraPEALut (1 mg/kg, intraperitoneally) daily for 72 h after SCI. The treatment increased the numbers of bromodeoxyuridine-positive nuclei and doublecortin-immunoreactive cells. Co-ultraPEALut administration stimulated expression of the neurotrophic factors brain-derived neurotrophic factor, glial cell-derived neurotrophic factor, nerve growth factor, and neurotrophin-3. These findings show a prominent effect of co-ultraPEALut administration in the management of survival and differentiation of new neurons and spine maturation.

Study Duration
72 h after SCI for most experiments, 21 days for motor score evaluation
Participants
Male CD1 mice weighing 25–30 g
Evidence Level
Not specified

Key Findings

  • 1
    Co-ultraPEALut increased the numbers of both bromodeoxyuridine-positive nuclei and doublecortin-immunoreactive cells in the spinal cord of injured mice, indicating increased cell proliferation and neurogenesis.
  • 2
    Co-ultraPEALut administration stimulated expression of the neurotrophic factors brain-derived neurotrophic factor, glial cell-derived neurotrophic factor, nerve growth factor, and neurotrophin-3, suggesting a mechanism for promoting neuronal survival and differentiation.
  • 3
    Co-ultraPEALut administration stimulated the remodeling of dendritic arbors in the injured area, indicating an effect on synaptic plasticity and neuronal circuit reorganization.

Research Summary

This study investigated the neuroregenerative properties of co-ultraPEALut in a murine model of spinal cord injury (SCI). The findings demonstrated that co-ultraPEALut treatment increased cell proliferation and neurogenesis in the injured spinal cord. Co-ultraPEALut administration stimulated the expression of neurotrophic factors and promoted dendritic remodeling, suggesting a potential mechanism for its neuroregenerative effects. The results suggest that co-ultraPEALut may represent a novel therapeutic approach for improving neurological outcomes after SCI by promoting neuroprotection, neuroregeneration, anti-inflammation, and anti-apoptosis.

Practical Implications

Therapeutic Potential

Co-ultraPEALut may be a novel therapeutic approach for treating spinal cord injury.

Neuroregeneration

The study suggests that co-ultraPEALut can promote neuroregeneration after SCI.

Clinical Implications

The composite was administered after trauma, simulating the clinical condition, suggesting clinical relevance.

Study Limitations

  • 1
    The study was conducted on a murine model, and the results may not be directly applicable to humans.
  • 2
    The exact mechanisms by which co-ultraPEALut exerts its neuroregenerative effects remain to be fully elucidated.
  • 3
    Further research is needed to determine the optimal dosage and administration schedule for co-ultraPEALut in the treatment of SCI.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury